Selective mutism, social phobia and moclobemide: A case report

Abstract

The literature on childhood elective/selective mutism and its relationship to social phobia is reviewed briefly. A chronic case, resistant to multiple psychological treatments, is described. The results of a novel treatment approach with moclobemide, a reversible monoamine oxidase inhibitor, are evaluated and discussed.